In this review, we found that TGR5-dependent signaling pathways can promote the development and migration of lung cancer, endometrial cancer, and pancreatic cancer; meanwhile, it can inhibit the proliferation and migration of liver cancer, gastric cancer, colorectal cancer, and breast cancer. Here, GPBAR1 is linked to breast carcinoma.